Longboard Pharmaceuticals Inc (NAS:LBPH)
$ 34.785 1.385 (4.15%) Market Cap: 1.35 Bil Enterprise Value: 1.01 Bil PE Ratio: 0 PB Ratio: 4.59 GF Score: 36/100

Q4 2022 Longboard Pharmaceuticals Inc Earnings Call Transcript

Mar 02, 2023 / 09:30PM GMT
Release Date Price: $5.26 (-4.88%)
Operator

Good day and thank you for standing by. Welcome to the Longboard Pharmaceuticals conference call. (Operator Instructions) Please be advised that today's conference is being recorded. I'd now like to hand the conference over to your speaker today, Brandi Roberts, Chief Financial Officer. Please go ahead.

Brandi Roberts
Longboard Pharmaceuticals, Inc. - EVP & CFO

Thank you. And good afternoon, everyone. Welcome to Longboard's conference call and webcast where we will be discussing our 2022 financial results and providing a corporate review of the past year and an update on the year ahead.

Before we begin today, I would like to remind everyone that this conference call and webcast will contain forward-looking statements about the company including, without limitation, statements about the anticipated timing of commencement, enrollment, and completion of clinical trials for our product candidates; the anticipated timing of release of clinical trial data; the market opportunity for our product candidates; and the expected timeframe for funding

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot